XML 230 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangements [Abstract]  
Disclosure of Weighted Assumptions Used in the Black-Scholes Option Pricing Model The fair value of the private warrants was determined using the Black-Scholes option pricing model taking into account the following assumptions:
September 30, 2022December 31, 2021
Exercise price ($)11.5011.50
Share price ($)2.869.94
Volatility47%40%
Risk-free interest rate3.59%1.27%
Expected warrant life (years)3.584.33
The following principal weighted assumptions were used in the Black-Scholes option pricing model to remeasure the share-based compensation liability relating to stock options as at May 6, 2021:

May 6, 2021
Exercise price (CA $)1.17
Share price (CA $)19.73
Volatility (%)40%
Risk-free interest rate (%)1.40%
Expected option life (years)7.58
The following table summarizes the weighted average values for the assumptions used in the Black-Scholes option pricing model for the stock option grants during the nine months ended September 30, 2022 and year ended December 31, 2021. There were no stock option grants during the three months ended September 30, 2022.
September 30, 2022December 31, 2021
Expected dividends per share (CA$)——
Exercise price (CA$)6.9421.86
Share price (CA$)6.9421.86
Expected Volatility (%)40%40%
Risk-free interest rate (%)2.78%1.16%
Expected option life (years)7.507.50
Disclosure of Outstanding Options
The following table summarizes the outstanding options as at and changes during the nine months ended and year then ended:
September 30, 2022December 31, 2021
Number of stock optionsWeighted average exercise priceNumber of stock optionsWeighted average exercise price
CA$CA$
Outstanding, beginning of period9,072,1491.8210,375,1951.17
Granted558,6976.94294,85421.86
Exercised——(1,505,000)0.93
Forfeited(7,573)9.62(92,900)6.90
Outstanding, end of period9,623,2732.119,072,1491.82
Exercisable, end of period6,825,3251.245,054,9761.06
Disclosure of Information Relating to Stock Options Outstanding
The following table summarizes the information relating to stock options outstanding:

As at September 30, 2022
Number of stock optionsRemaining contractual life (years)Number of stock options exercisable
Exercise price
CA$0.93 (issued in 2018)
4,792,3985.194,644,838
CA$0.93 (issued in 2019)
3,664,9077.022,007,201
CA$6.90 (issued in 2020)
319,9907.96103,223
CA$15.45 (issued in 2021)
26,3898.906,597
CA$23.02 (issued in 2021)
253,8658.7463,466
CA$13.29 (issued in 2021)
14,6009.19—
CA$6.92 (issued in 2022)
486,0419.62—
CA$7.05 (issued in 2022)
65,0839.64—
9,623,2736,825,325


As at December 31, 2021
Number of stock optionsRemaining contractual life (years)Number of stock options exercisable
Exercise price
CA$0.93 (issued in 2018)
4,792,3985.943,316,799
CA$0.93 (issued in 2019)
3,664,9077.771,634,954
CA$6.90 (issued in 2020)
319,9908.71103,223
CA$15.45 (issued in 2021)
26,3899.65—
CA$23.02(issued in 2021)
253,8659.49—
CA$13.29 (issued in 2021)
14,6009.94—
9,072,1495,054,976
Disclosure of share-based payment arrangements compensation expense Compensation expense related to the stock options was recognized in the consolidated statement of earnings (loss) as follows:
Three months endedNine months ended
September 30, 2022September 30, 2021September 30, 2022September 30, 2021
$$$$
Administrative expenses1,878,0494,473,5946,750,16052,293,945
Selling expenses631,423 1,522,5972,398,950 13,707,094
2,509,4725,996,1919,149,11066,001,039
Compensation expense related to the RSUs was recognized in the consolidated statement of earnings (loss) is as follows:
Three months endedNine months ended
September 30, 2022September 30, 2021September 30, 2022September 30, 2021
$$$$
Administrative expenses133,118—271,808—
Selling expenses39,880 — 83,393 — 
172,998—355,201—
Compensation expense related to the DSUs was recognized in the consolidated statement of earnings (loss) is as follows:
Three months endedNine months ended
September 30, 2022September 30, 2021September 30, 2022September 30, 2021
$$$$
Administrative expenses——335,799—
——335,799—
Disclosure of Equity Instruments Measured at Fair Value
The following table summarizes the information relating to restricted share units outstanding:.
September 30, 2022December 31, 2021
Number of restricted share unitsWeighted average exercise priceNumber of restricted share unitsWeighted average exercise price
CA$CA$
Outstanding, beginning of period36,24718.59——
Granted276,5846.9336,24718.59
Forfeited(15,173)6.92——
Outstanding, end of period297,6588.3536,24718.59
Vested, end of period————
September 30, 2022December 31, 2021
Number of deferred share unitsWeighted average exercise priceNumber of deferred share unitsWeighted average exercise price
CA$CA$
Outstanding, beginning of period18,75514.07——
Granted62,1816.9218,75514.07
Settled 2,02614.07——
Outstanding, end of period78,9108.4418,75514.07
Vested, end of period78,9108.4418,75514.07